What does Jagadishwar Pharmaceutical Works Limited do?

Jagadishwar Pharmaceutical Works Limited is a pharmaceutical manufacturing company based in Guwahati, Assam. It is engaged in the manufacturing and distribution of pharmaceutical formulations (tablets, capsules, syrups, etc.) primarily serving the Northeast Indian market.

Where is Jagadishwar Pharmaceutical Works Limited located?

The company is headquartered in Guwahati, Kamrup district, Assam. Guwahati serves as the commercial gateway to Northeast India.

When was Jagadishwar Pharmaceutical Works Limited incorporated?

The company was incorporated in 1987 and is registered with the Registrar of Companies, Assam (CIN: L24232AS1987PLC002803).

Is Jagadishwar Pharmaceutical Works listed on any stock exchange?

No, Jagadishwar Pharmaceutical Works Limited is an unlisted public limited company. Its shares are not traded on BSE or NSE.

What is the ISIN of Jagadishwar Pharmaceutical Works Limited?

The ISIN of Jagadishwar Pharmaceutical Works Limited is INE832F01017.

Who am I actually transacting with?

You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.

How do I pay, and is there a payment gateway?

Payment is by direct bank transfer to Prospire Network Private Limited's published account (CIN U82300UP2025PTC233622), shown to you in-app at the payment step. There is no card gateway and no escrow. Never pay to a personal account or to any account shared over phone, WhatsApp or email — even if the person claims to be from our team.

How long does settlement take?

After you accept an allocation, you have a short window to pay (typically 2 days). Once payment is verified, shares are usually credited to your demat within 2–3 business days, subject to depository timelines and any company-level restrictions. Timeframes are typical, not guaranteed.

There are no separate platform fee lines and no GST on the transfer — the desk's margin is built into the buy/sell price you're quoted. The only statutory add-on on a purchase is stamp duty on the consideration, shown transparently in your cost breakdown.

Is there a minimum ticket size for Jagadishwar Pharmaceutical Works Limited?

Minimums vary by company and depend on the lot the desk can source. Raise an enquiry and the desk will confirm the available quantity and the minimum for that name.

What KYC do I need, and do I need a demat account?

You'll share your demat details when you enquire so we can settle directly. Full KYC — PAN and a client-master / demat statement — is required before the transfer step, when shares actually change hands. Yes, you need an active demat account to hold unlisted shares.

Are there lock-ins on unlisted or pre-IPO shares?

Some shares carry statutory or company-imposed lock-ins — for example, a post-listing lock-in on pre-IPO stock — and transfers can be subject to the company's articles or approvals. Where a lock-in applies, we'll flag it before you commit.

How do I sell Jagadishwar Pharmaceutical Works Limited shares I already hold?

Raise a sell enquiry with the company, quantity and your target price. The desk confirms a buying price, you transfer your shares into the desk's demat, and once the credit is verified we pay you out by bank transfer to your registered account. The desk never pays out before your shares are received.

Unlisted shares are illiquid, may be hard or impossible to sell, and are not covered by exchange settlement guarantees or investor-protection funds. Pricing is indicative, not live. Read the full Risk Disclosure before you enquire, and invest only what you can afford to lock away.

Jagadishwar Pharmaceutical Works Limited Unlisted Share Price | Buy Jagadishwar Pharmaceutical Works Limited Pre-IPO Shares — wisefolio

Unlisted shares are illiquid and carry higher risk than listed securities. Prices are indicative, not live. Read the risk disclosure.

Talk to us

Jagadishwar Pharmaceutical Works Limited Unlisted Share Price | Buy Jagadishwar Pharmaceutical Works Limited Pre-IPO Shares — wisefolio | wisefolio

Investment Thesis

Jagadishwar Pharmaceutical Works Limited is a small, long-standing regional pharmaceutical manufacturer serving Northeast India from its Guwahati base. With nearly four decades of regional presence, it has established local market knowledge and distribution relationships. However, limited scale, lack of public financial disclosure, and growing competition from national players limit its investment appeal. The company serves an important healthcare supply role in an underserved region but faces structural challenges in scaling up or competing with larger players.

Pros

Incorporated in 1987, giving the company nearly four decades of pharmaceutical industry experience in Assam
Guwahati is the commercial and pharmaceutical hub of Northeast India, providing strategic access to the seven sister states — a vast underserved pharmaceutical market
Northeast India has historically been an underpenetrated market for pharmaceutical companies, offering relatively lower competition compared to major metro markets
Regional pharmaceutical manufacturers often benefit from lower operating costs (land, labor, utilities) compared to counterparts in Gujarat, Maharashtra, or Himachal Pradesh
Pharmaceutical sector in India continues to see strong long-term demand driven by aging population, rising healthcare awareness, and expanding insurance coverage

Cons

Very limited publicly available financial or operational information as an unlisted company
Small regional pharmaceutical manufacturer with significantly limited scale compared to large generic drug companies
Northeast India's infrastructure challenges (logistics, transportation, power supply) can increase operational costs and distribution complexity
Pharmaceutical manufacturing requires strict compliance with CDSCO, WHO-GMP, and state FDA regulations; small manufacturers may face compliance challenges
Share price at INR 10 (face value) suggests minimal market pricing and very low investor activity
Competition from large national pharma companies (Sun Pharma, Cipla, Dr. Reddy's) with superior distribution, brand power, and R&D capabilities

Business Segments

Pharmaceutical Formulations Manufacturing

Manufacturing of finished pharmaceutical dosage forms including tablets, capsules, oral liquids (syrups, suspensions), and topical preparations. Products are sold under generic or branded generic names to distributors, hospitals, and chemist shops in Northeast India.

Pharmaceutical Distribution & Trading

Distribution and trading of pharmaceutical products sourced from other manufacturers for sale in the Northeast Indian market, supplementing own manufacturing revenue.

Other / Institutional Supply

Supply of medicines to government health programs, hospitals, and institutions in Assam and neighboring states through tender-based procurement.

Revenue Model

Jagadishwar Pharmaceutical generates revenue primarily through the sale of self-manufactured pharmaceutical formulations to distributors, stockists, and retailers across Northeast India. Additional revenue comes from trading in pharmaceutical products sourced from other manufacturers. Government institutional supply through tenders may provide a portion of steady revenue. The company operates in the branded generic model typical of small regional pharma manufacturers.

Detailed Analysis

Growth outlookExpansion plans, industry tailwinds & headwinds12

Growth Plans

Growing pharmaceutical consumption in Northeast India driven by rising incomes, healthcare awareness, and government health insurance schemes (PM-JAY)

Government of Assam and Central NDA focus on infrastructure and healthcare development in Northeast India improving institutional demand

Northeast India's relative insulation from large MNC pharma competition in certain segments

Ayushman Bharat scheme expanding healthcare access and drug consumption at primary healthcare levels

Recent Developments

Northeast India pharmaceutical market expansion

The Northeast Indian pharmaceutical market has seen increasing penetration from national chains and large generic manufacturers, creating both competitive pressure and market expansion opportunities for regional manufacturers like Jagadishwar.

2023-2024

Assam healthcare infrastructure investment

The Government of Assam and Central Government have invested significantly in healthcare infrastructure in the state, including expansion of AIIMS Guwahati and district hospital networks, potentially increasing institutional pharmaceutical demand.

2022-2023

Post-COVID pharmaceutical demand surge

The COVID-19 pandemic led to increased awareness and demand for pharmaceuticals including vitamins, analgesics, and respiratory medications, temporarily boosting demand for regional pharmaceutical manufacturers.

Comparable Companies

CompanyTypeTickerMkt Cap

Alkem Laboratories LimitedListedALKEM~INR 40,000 Cr

Mankind Pharma LimitedListedMANKIND~INR 90,000 Cr

Elder Pharmaceuticals LimitedListedELDERPHARM~INR 200 Cr (small cap)

Alkem Laboratories LimitedListed

ALKEM · ~INR 40,000 Cr

Frequently Asked Questions

About Jagadishwar Pharmaceutical Works Limited

Jagadishwar Pharmaceutical Works Limited is a publicly listed pharmaceutical company incorporated on 20 November 1987 under CIN L24232AS1987PLC002803, registered with the Registrar of Companies, Shillong and headquartered at 205 Haribol Roy Market, 2nd Floor, A.T. Road, Guwahati, Assam 781001. The company is listed on the Metropolitan Stock Exchange of India (MSEI) and operates as a small-scale manufacturer and marketer of pharmaceutical products in northeastern India. The company's principal activities encompass the manufacture of pharmaceutical formulations, chemical preparations, drugs, compounds, and medicinal products, alongside investment and financing activities in securities and instruments. This dual mandate — pharmaceuticals manufacturing combined with investment portfolio management — is characteristic of several MSEI-listed micro-cap companies that maintain core manufacturing operations alongside treasury management. Jagadishwar Pharmaceutical Works reported revenues of approximately Rs. 44.14 lakhs for FY2022-23, compared to Rs. 52.46 lakhs in FY2021-22, reflecting a modest decline. Despite the revenue contraction, the company remained profitable with a profit after tax of Rs. 6.32 lakhs in FY2022-23 versus Rs. 9.38 lakhs in FY2021-22. The authorized share capital stands at Rs. 29.75 crore against paid-up capital of Rs. 29.70 crore — an unusually high capitalization relative to revenues, indicating the company may hold significant investment assets. The company's operations are primarily focused on Northeast India, serving regional pharmaceutical distribution channels. Its registered compliance officer is Sonam Agarwal who also serves as Company Secretary. Key directors include Swapan Sarkar, Gunadhar Ghosh, Kakali Ghosh, and Sandip Kumar Singh. The company has consistently filed its financial statements and maintains active status with MCA as of 2024. Guwahati has emerged as a significant pharmaceutical hub in Northeast India with growing demand for affordable generic medicines and healthcare infrastructure — a market context favorable for regional manufacturers like Jagadishwar. The company benefits from proximity to markets in Assam, Meghalaya, and the broader Seven Sisters states.

Key Milestones

Common questions about unlisted shares

How do I buy Jagadishwar Pharmaceutical Works Limited unlisted shares here?
Raise an enquiry on any company with the quantity you want. Our desk sources the shares and comes back with a firm price and allocation. You accept the allocation, transfer the funds to the desk's published bank account, and once we verify payment the shares are transferred into your demat.
Who am I actually transacting with?
You transact with the desk, not with an anonymous counterparty. When you buy, you buy from the desk; when you sell, you sell to the desk. Shares always route through the desk's own demat account, so there's one accountable party for the whole trade.
How do I pay, and is there a payment gateway?

Risk factors & red flagsInvestment risks and items flagged from public filings10

Regulatory / LegalLow

Pharmaceutical manufacturing requires strict compliance with CDSCO (Central Drugs Standard Control Organisation) regulations, WHO-GMP guidelines, and Assam State Drug Authority requirements. Non-compliance can result in product recalls or manufacturing license cancellations.

Source: Regulatory Filings

Fraud / GovernanceLow

Northeast India is increasingly targeted by large national pharma companies (Sun Pharma, Cipla, Alkem, Mankind) with superior product portfolios, marketing spend, and distribution infrastructure, intensifying competition for regional manufacturers.

Source: Media Reports / Public Records

Industry / CompetitionLow

Logistics and cold chain infrastructure in Northeast India remain a challenge. Transportation costs, road connectivity issues, and occasional natural disasters (floods in Assam) can disrupt supply chains and operations.

Source: AlphaHub Research

Fraud / GovernanceLow

Active Pharmaceutical Ingredients (APIs) and excipients are largely imported or sourced from mainland India. Supply disruptions and price increases in API markets (notably post-COVID China supply chain issues) can impact production costs.

Source: Media Reports / Public Records

Fraud / GovernanceLow

As a small, unlisted regional company with shares at face value, there is virtually no secondary market liquidity. Investors face significant challenges in exiting their positions.

Source: Media Reports / Public Records

Regulatory Compliance Risk

Competition Risk

Infrastructure Risk

Raw Material Risk

Liquidity Risk

As a small, unlisted regional company with shares at face value, there is virtually no secondary market liquidity. Investors face significant challenges in exiting their positions.

Jagadishwar Pharmaceutical Works Limited

How settlement works

Get price alerts for Jagadishwar Pharmaceutical Works Limited

Discuss Jagadishwar Pharmaceutical Works Limited

Other ways to invest